Present status of ganglion blocking drugs. 1967

J G Hilton, and J C Hancock

UI MeSH Term Description Entries
D005730 Ganglionic Blockers Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery. Ganglionic Blocking Agents,Ganglioplegic Agents,Blocking Agents, Ganglionic,Ganglionic Blockaders,Agents, Ganglionic Blocking,Agents, Ganglioplegic,Blockaders, Ganglionic,Blockers, Ganglionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J G Hilton, and J C Hancock
January 1957, Archivos del Instituto de Farmacologia Experimental (Medicina),
J G Hilton, and J C Hancock
May 1956, HNO,
J G Hilton, and J C Hancock
January 1956, Archivum immunologiae et therapiae experimentalis,
J G Hilton, and J C Hancock
January 1957, Anesthesie, analgesie, reanimation,
J G Hilton, and J C Hancock
March 1960, British journal of pharmacology and chemotherapy,
J G Hilton, and J C Hancock
April 1957, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
J G Hilton, and J C Hancock
June 1956, Giornale italiano di chirurgia,
J G Hilton, and J C Hancock
June 1956, British medical journal,
J G Hilton, and J C Hancock
January 1961, The Practitioner,
Copied contents to your clipboard!